Treximet Oral Tablet 85-500Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Treximet: Oral tablet (85-500mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Treximet 85mg-500mg Tab
Drug Image file DrugItem_18768.JPG
Treximet 85mg-500mg Tab
GlaxoSmithKline Group of Companies
Pill Identification: TREXIMET 
Drug Image file DrugItem_18768.JPG
Treximet 85mg-500mg Tab
GlaxoSmithKline Group of Companies
Pill Identification: TREXIMET 

What is this Medicine?

NAPROXEN; SUMATRIPTAN (na PROS en; soo ma TRIP tan) is used to treat migraines with or without aura. An aura is a strange feeling or visual disturbance that warns you of an attack. This medicine is not used to prevent migraines.

CVS Pharmacy Patient Statistics for Treximet: Oral tablet(85-500mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Treximet 85mg-500mg Tablet

NDC: 652240850
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Storage Information
Store in original container
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Treximet 85mg-500mg Tablet
Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Treximet

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.